USP17L14P

Across TCGA pan-cancer cohorts, USP17L14P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated USP17L14P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher USP17L14P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP17L14P expression acts as an unfavorable survival marker.

MESO, LUSC, and ACC are the cancer types where USP17L14P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	108	view →
LUSC	OS	Tertile	II,III,IV	0.250	0.778	.007	36	view →
ACC	DFS	Tertile	All	0.195	0.748	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

USP17L14P–MESO (OS)

Open the MESO breakdown →